To screen efficiently the millions of compounds that are synthesized using combinatorial and automated methods, dramatically improved assay technologies are currently needed. In 96-well microtiter plates, nonradioactive techniques (primarily fluorimetric) and cell-based functional methods have moved
High-throughput screening technologies for drug glucuronidation profiling
β Scribed by Olga Trubetskoy; Moshe Finel; Vladimir Trubetskoy
- Book ID
- 111770864
- Publisher
- Pharmaceutical Press
- Year
- 2008
- Tongue
- English
- Weight
- 297 KB
- Volume
- 60
- Category
- Article
- ISSN
- 2042-7158
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
The use of high-throughput screening for early stage drug discovery imposes several constraints on the format of assays for therapeutic targets of interest. Homogeneous cell-free assays based on energy transfer, fluorescence polarization spectroscopy or fluorescence correlation spectroscopy provide
Both isotopic and nonisotopic assay methodologies are employed in high-throughput screening for drug discovery. Recent advances in cell-based and in vitro biochemical assays will be reviewed, with special emphasis on detection technologies amenable to automated 'mix and read' procedures in high-thro
A variety of assay technologies continue to be developed for high-throughput screening. These include cell-based assays, surrogate systems using microbial cells such as yeast and bacterial two-hybrid and three-hybrid systems, and systems to measure nucleic acid-protein and receptor-ligand interactio